Angiotech extends exclusive licensing agreement with Poly-Med for biomaterial technologies
15-Apr-2004 -
Vancouver. Angiotech Pharmaceuticals, Inc., a specialty pharmaceutical company focusing on drug-coated medical devices and biomaterials, today announced that it has licensed a portfolio of biomaterial, drug delivery, and medical device technologies from Poly-Med, Inc. This agreement will expand ...
biomaterials
biopolymers
clinical trials
+7